Burning Rock Biotech BNR Ratios (2019-2026)

NASDAQ BNR
$10.00 -0.44 (-4.21%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Burning Rock Biotech Quarterly Ratios

Periods 29 quarters
Latest Mar 2026

Burning Rock Biotech reported a gross margin of 72.27% and a net margin of -16.18% for the quarter ended Mar 2026. These financial ratios cover 29 quarters of results from Mar 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin
70.89%72.34%71.52%64.62%63.13%70.23%71.20%69.30%68.65%67.35%64.51%68.21%70.42%71.40%70.96%73.18%72.77%75.10%78.03%72.27%
EBT Margin
-158.74%-134.31%-171.22%-192.87%-200.29%-149.70%-150.68%-129.69%-89.42%-136.80%-133.09%-96.61%-79.57%-27.64%-60.29%-9.98%-6.37%-12.58%-11.48%-15.96%
EBIT Margin
-158.73%-135.09%-171.11%-193.72%-202.90%-151.74%-152.88%-132.75%-96.06%-140.16%-137.37%-100.16%-82.37%-30.00%-65.01%-11.39%-7.67%-12.19%-9.53%-17.39%
EBITDA Margin
-158.73%-135.09%-171.11%-193.72%-202.90%-151.74%-152.88%-132.75%-96.06%-140.16%-137.37%-100.16%-82.37%-30.00%-65.01%-11.39%-7.67%-12.19%-9.53%-17.39%
Operating Margin
-158.73%-135.09%-171.11%-193.95%-202.90%-151.74%-152.88%-132.24%-92.79%-140.16%-137.37%-100.16%-82.06%-30.00%-65.01%-11.41%-7.74%-12.26%-9.53%-17.45%
Net Margin
-160.02%-134.65%-170.44%-192.87%-200.36%-149.70%-152.02%-129.99%-89.72%-137.16%-133.97%-96.76%-79.71%-27.79%-65.55%-10.15%-6.53%-12.74%-12.17%-16.18%
FCF Margin
-93.51%-105.37%-76.24%-106.39%-83.54%-87.60%-46.16%-79.70%-56.06%-37.17%-13.23%-32.01%-60.03%-86.54%15.12%-17.65%-45.25%12.39%18.23%-27.03%
Efficiency
Inventory AverageInventory Avg.
16.32M17.85M3.75M5.03M19.95M20.25M9.05M6.77M15.30M12.94M10.72M9.16M8.90M9.26M8.48M8.25M8.54M7.86M7.84M7.95M
Assets AverageAssets Avg.
401.37M384.94M366.47M344.44M305.19M260.63M233.29M214.79M194.95M171.72M152.18M140.43M138.62M140.58M131.79M120.52M116.47M114.62M114.88M114.94M
Invested CapitalInvested Cap.
4.67M0.37M0.35M0.03M0.03M0.03M
Asset Utilization RatioAsset Util.
0.190.200.210.240.270.330.360.380.430.460.500.510.510.510.540.600.640.650.660.63
Leverage & Solvency
Interest Coverage RatioInterest Cover
355.57465.720.00M0.00M860.500.00M
Debt Ratio
0.010.000.000.000.000.000.00
Times Interest Earned
355.57465.720.00M0.00M860.500.00M
Valuation
Enterprise Value
-331.94M-296.63M-225.09M-228.18M-172.81M-162.69M-130.10M-136.66M-114.77M-100.57M-85.45M-85.21M-85.05M-87.71M-72.69M-72.14M-72.51M-65.66M-67.83M-69.85M
Return Ratios
Return on SalesROS
-0.02%-0.01%-0.02%-0.02%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%
Return on Capital EmployedROCE
-28.12%-31.99%-40.11%-49.33%-58.51%-73.30%-82.97%-80.97%-76.19%-78.44%-82.06%-80.66%-78.46%-59.49%-52.27%-39.87%-24.19%-21.03%-9.56%-10.15%
Return on Invested CapitalROIC
-0.51%-2.12%-2.70%-3.71%-5.88%-1.78%-1.15%
Return on AssetsROA
0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%